Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Department of Ophthalmology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Hum Gene Ther. 2020 Oct;31(19-20):1054-1067. doi: 10.1089/hum.2020.118.
Recombinant adeno-associated viral (rAAV) vector mobilization is a largely theoretical process in which intact AAV vectors spread or "mobilize" from transduced cells and infect additional cells within, or external of, the initial host. This process can be helper virus-independent (vector alone) or helper virus-dependent ( rAAV production facilitated by superinfection of both wild-type AAV [wtAAV] and Adenovirus 5 [Ad] helper virus). Herein, rAAV production and mobilization with and without wtAAV were analyzed following plasmid transfection or viral transduction utilizing well-established conditions and analytical measurements. During production, wtAAV produced the highest titer with rAAV-luc (4.1 kb), rAAV-IDUA (3.7 kb), and rAAV-Nano-dysferlin (4.9 kb) generating 2.5-, 5.9-, or 10.7-fold lower amounts, respectively. Surprisingly, cotransfection of a wtAAV and an rAAV plasmid resulted in a uniform decrease in production of wtAAV in all instances with a concomitant increase of rAAV such that wtAAV:rAAV titers were at a ratio of 1:1 for all constructs investigated. These results were shown to be independent of the rAAV transgenic sequence, size, transgene, or promoter choice and point to novel aspects of wtAAV complementation that enhance current vector production systems yet to be defined. In a mobilization assay, a sizeable amount of rAAV recovered from infected 293 cell lysate remained intact and competent for a secondary round of infection (termed Ad-independent mobilization). In rAAV-infected cells coinfected with Ad and wtAAV, rAAV particle production was increased >50-fold compared with no Ad conditions. In addition, Ad-dependent rAAV vectors mobilized and resulted in >1,000-fold transduction upon a subsequent second-round infection, highlighting the reality of these theoretical safety concerns that can be manifested under various conditions. Overall, these studies document and signify the need for mobilization-resistant vectors and the opportunity to derive better vector production systems.
重组腺相关病毒 (rAAV) 载体的转导是一个很大程度上的理论过程,其中完整的 AAV 载体从转导的细胞中扩散或“转导”,并感染初始宿主内或外部的其他细胞。这个过程可以是辅助病毒独立的(仅载体),也可以是辅助病毒依赖的(通过野生型 AAV [wtAAV] 和腺病毒 5 [Ad] 辅助病毒的超感染来促进 rAAV 的产生)。本文中,我们分析了在质粒转染或病毒转导后,有无 wtAAV 存在时 rAAV 的产生和转导情况,使用了成熟的条件和分析测量方法。在生产过程中,wtAAV 产生 rAAV-luc(4.1kb)、rAAV-IDUA(3.7kb)和 rAAV-Nano-dysferlin(4.9kb)的滴度最高,分别产生低 2.5 倍、5.9 倍和 10.7 倍的量。令人惊讶的是,wtAAV 和 rAAV 质粒的共转染导致所有情况下 wtAAV 的产量均匀下降,同时 rAAV 的产量增加,使得 wtAAV:rAAV 的滴度比为所有研究的构建体均为 1:1。这些结果显示与 rAAV 转基因序列、大小、转基因或启动子选择无关,指向 wtAAV 互补的新方面,增强了当前尚未定义的载体生产系统。在转导测定中,从感染的 293 细胞裂解物中回收的大量 rAAV 保持完整并具有进行第二轮感染的能力(称为 Ad 独立转导)。在与 Ad 和 wtAAV 共感染的 rAAV 感染细胞中,rAAV 颗粒的产量与没有 Ad 的条件相比增加了>50 倍。此外,Ad 依赖性 rAAV 载体转导并在随后的第二轮感染中导致>1000 倍的转导,突出了这些理论安全性问题的现实性,这些问题可以在各种条件下表现出来。总的来说,这些研究记录并表明需要使用抗转导的载体,并有机会开发更好的载体生产系统。